Search
for
Sort by
Research 361–390 of 1000+
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.) L.
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Skin disease in pregnancy
- Androgen antagonists in androgen target tissues
- Skin disease in pregnancy
- Scleroderma and L-tryptophan: A possible explanation of the eosinophilia-myalgia syndrome
- Novel inhibitors of 5α-reductase
- Congenital adrenal hyperplasia
- Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens
- Diseases on Hair Follicles Leading to Hair Loss Part I: Nonscarring Alopecias
- Topical Treatments for Scalp Psoriasis
- Hair loss
- Urticaria induced by laser epilation: A clinical and histopathological study with extended follow‐up in 36 patients
- Disorders of hair
- Mechanisms of Puerariae Lobatae Radix in regulating sebaceous gland secretion: insights from network pharmacology and experimental validation
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes
- A Rare Case of Antinuclear Antibody-Negative Systemic Lupus Erythematosus Presenting With Generalized Lymphadenopathy as the Initial Manifestation
- A clinical study of pemphigus vulgaris and its variants, evaluation of safety and efficacy of glucocorticoids versus immunosuppressants at tertiary care hospital: a study of 75 cases
- Hypersensitivity Diseases
- Psoriasis
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions
- Graft-versus-host disease
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Establishment of type II 5α-reductase over-expressing cell line as an inhibitor screening model
- BH07: Testosterone deficiency in men with female pattern hair loss
- Cutaneous calcinosis of scleroderma. Successful treatment with intralesional adrenal steroids.